Bariatric Surgery Safe for Compensated Cirrhosis Patients
By HospiMedica International staff writers Posted on 07 Jan 2019 |
Patients suffering from non-alcoholic steatohepatitis (NASH) and cirrhosis can still benefit from bariatric surgery, especially vertical sleeve gastrectomy, according to a new study.
Researchers at Ohio State University (OSU, Columbus, USA) conducted a study that collected data on 558,017 patients who underwent either Roux-en-Y gastric bypass or vertical sleeve gastrectomy in the United States between 2008 and 2013, of whom 3,189 (0.57%) had compensated cirrhosis and 103 (0.02%) had decompensated cirrhosis. They then analyzed demographics, health care utilization, and in-hospital outcomes, and compared hospital mortality, length of stay (LOS), and cost of care between patients with no cirrhosis, compensated cirrhosis, and decompensated cirrhosis.
The results revealed that the mortality rate in patients with compensated cirrhosis was comparable to those without cirrhosis, while mortality was higher in patients with decompensated cirrhosis. Other predictors of mortality were older age, male gender, Elixhauser Comorbidity Index score greater than 3, Roux-en-Y surgery, Medicare payment for the operation, and procedures conducted at medical centers performing less than 50 annual bariatric surgeries. The study was published in a 2018 DDW supplement of Gastroenterology.
“The majority of the patients underwent sleeve gastrectomy, which is a much less invasive surgery than the Roux-en-Y procedure. We also found that patients do better in larger centers that do more than 100 bariatric surgeries per month,” said senior author Khalid Mumtaz, MD. “Patients with decompensated cirrhosis--ascites, jaundice, and hepatitis B or C--should not be considered for bariatric surgery; these patients had a 98 times increased risk of mortality. If our goal is to save lives, we would not recommend an elective procedure like gastric bypass for these patients.”
The majority of patients who undergo bariatric surgery suffer from NASH and obesity-related cirrhosis, and previous studies have shown an increased risk for death within 10 years of bariatric surgery in such patients, as well as increased perioperative mortality.
Related Links:
Ohio State University
Researchers at Ohio State University (OSU, Columbus, USA) conducted a study that collected data on 558,017 patients who underwent either Roux-en-Y gastric bypass or vertical sleeve gastrectomy in the United States between 2008 and 2013, of whom 3,189 (0.57%) had compensated cirrhosis and 103 (0.02%) had decompensated cirrhosis. They then analyzed demographics, health care utilization, and in-hospital outcomes, and compared hospital mortality, length of stay (LOS), and cost of care between patients with no cirrhosis, compensated cirrhosis, and decompensated cirrhosis.
The results revealed that the mortality rate in patients with compensated cirrhosis was comparable to those without cirrhosis, while mortality was higher in patients with decompensated cirrhosis. Other predictors of mortality were older age, male gender, Elixhauser Comorbidity Index score greater than 3, Roux-en-Y surgery, Medicare payment for the operation, and procedures conducted at medical centers performing less than 50 annual bariatric surgeries. The study was published in a 2018 DDW supplement of Gastroenterology.
“The majority of the patients underwent sleeve gastrectomy, which is a much less invasive surgery than the Roux-en-Y procedure. We also found that patients do better in larger centers that do more than 100 bariatric surgeries per month,” said senior author Khalid Mumtaz, MD. “Patients with decompensated cirrhosis--ascites, jaundice, and hepatitis B or C--should not be considered for bariatric surgery; these patients had a 98 times increased risk of mortality. If our goal is to save lives, we would not recommend an elective procedure like gastric bypass for these patients.”
The majority of patients who undergo bariatric surgery suffer from NASH and obesity-related cirrhosis, and previous studies have shown an increased risk for death within 10 years of bariatric surgery in such patients, as well as increased perioperative mortality.
Related Links:
Ohio State University
Latest Surgical Techniques News
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures
- Cutting-Edge Imaging Platform Detects Residual Breast Cancer Missed During Lumpectomy Surgery
- Computational Models Predict Heart Valve Leakage in Children
- Breakthrough Device Enables Clear and Real-Time Visual Guidance for Effective Cardiovascular Interventions
- World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis
- World’s Smallest Implantable Brain Stimulator Demonstrated in Human Patient
- Robotically Assisted Lung Transplants Could Soon Become a Reality
- AI to Provide Heart Transplant Surgeons with New Decision-Making Data
- New Surgical Tool Empowers Precision and Confidence in Operating Room